2nd KEMRI Annual Scientific & Health Conference (KASH)

In order to view this object you need Flash Player 9+ support!

Get Adobe Flash player

Powered by RS Web Solutions

Friday, April 25, 2014
Text Size


Course Announcement

Job Opportunities

KEMRI Vacancies






RCTP Vacancies


In the News

prof-elizabeth-njeri-wamae-of-kemri-to-chair-nacostiThe Cabinet Secretary for Education, Science and Technology, Prof. Jacob Kaimenyi this week appointed Prof. Elizabeth Njeri Wame (pictured) to be...
official-inauguration-ceremony-of-the-independent-scientific-and-ethics-unit-isetu-offices The Chairlady of the KEMRI Board of Mangement, Prof Ruth Nduati, unveiling the plaque to officially inaugurate the New KEMRI Independent...
kemri-recruits-two-new-officers Mr. Anthony Wachira, Assistant Director in charge of Finance Dr. Cecilia M. Wanjala, Commercial Manager (Production). The...
coca-cola-vice-president-visits-kemri Dr. Nancy Quan, Global Vice President for Coco-Cola Research & Development (R&D) signs the Visitors Book when she visited KEMRI...

Business Opportunity

Disposal by Public Auction

Click Here



Calendar of Events

April 2014 May 2014
Su Mo Tu We Th Fr Sa
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30







Director, KEMRI Prof. Solomon Mpoke, confers with Dr. Kevin De Cock, (left) CDC-Kenya Director during a courtesy call on him by the Team from CDC-Procurement and Grant Management Office led by Ms. Angie Tuttle. Also present during the meeting were KEMRI's Deputy Director (Finance & Administration), Ms. Lina Boit, (right) Dr. John Vulule, KEMRI/CDC Cooperative Agreement Principle Investigator and Boniface Muthusi, Ag. CFO Grants.




During the COMESA Heads of State meeting in Kinshasa early this month KEMRI was awarded the 1st Prize for Innovations under Institution Category in recognition of the work that was done by the Production Department in Development of ELISA Test kit for Hepatitis B. The Award was presented to Production Manager, Dr. James Kimotho by HE Uganda's President Yoweri Kaguta Museveni on behalf of the Institute.

2nd KEMRI Annual Scientific & Health Conference (KASH)

Theme: Towards A Healthy, Globally Competitive Nation: Vision 2030 Flagships

Dr. Edwin Muinga

Dr. Edwin Muinga Chokwe, HSC,
Chairman, KEMRI Board of Management

Attaining Kenya Vision 2030, the nation's economic blueprint, requires a fresh perspective in the way we perceive research and KEMRI's role in national development. The link between health and poverty is self evident as each impacts the other resulting in a vicious cycle where poor health is both a result and a cause of poverty.

As such the dealing with one without being cognizant of the other only serves to derail the desired impact. Health research should therefore be linked to economic development through the promoting of human and social development, and also more directly through industrialization as we strive to attain a knowledge-economy driven, middle income status by the year 2030. This was reflected in the theme of this year's conference, "Towards a healthy, globally competitive nation: Vision 2030 flagships," which affirms KEMRI's role not just in human and social development but also in the knowledge economy through the innovation of R&D outputs.


Bridging the Gap in Health Research in Africa

This conference therefore serves to showcase excellence in research as the bedrock of this theme. Two major ground breaking research results emanating from research carried out by KEMRI and our collaborators have recently been listed among the top 10 technological breakthroughs of the year by the journal Science. This includes the phase III clinical trial results of the candidate malaria vaccine RTSS, which reported 56 percent and 47 percent efficacy in the prevention of clinical and severe malaria in children respectively. The multicentre trial was conducted in 11 sites across 7 African countries, in which KEMRI played a significant role, having hosted 3 of the 11 sites at the KEMRI/CDC Research and Public Health Collaboration in Kisumu, the KEMRI-Wellcome-Trust Research Programme in Kilifi and the KEMRI/Walter Reed Project site at Kombewa.

The other major breakthrough in which KEMRI has been involved is the HIV Prevention Trials Network (HPTN) multinational clinical study, HPTN 052, which demonstrated reduction of HIV transmission in serodiscordant couples through the early treatment of HIV using ARVs by an astounding 96 percent. Both studies have served to inform policy and revitalize the fight against the scourge of these diseases not just in Kenya but the world over.

Additionally, KEMRI remains committed to the national and WHO roadmaps for the control and elimination of 10 of the 17 neglected tropical diseases by the year 2020. Significant advances have been made on this front with results emanating from DNDi, of which KEMRI is both a founding member and partner through CCR, have informed the WHO recommendation of paramomycin-sodium

 stibogluconate (PM-SSG) drug combination as the first line treatment for visceral leishmaniasis in east Africa.

Further to the excellent research coming out of KEMRI, the conference also highlighted special areas of public health interest through dedicated symposia focusing on road safety, neglected tropical diseases, bioethics, health systems and social sciences research, all addressing aspects of health and human/social development.

For the first time, a symposium on pharmaceutical and health products innovation, focusing solely on the business of the science addressed aspects of knowledge economy and industrialization.

DKDr. Solomon Mpoke, PhD, MBS,
Director, KEMRI




The Chairlady of the KEMRI Board of Mangement, Prof Ruth Nduati, unveiling the plaque to officially inaugurate the New KEMRI Independent Scientific and Ethics Unit (KISETU) Office at KEMRI Headquarters Nairobi yesterday. Also present is Director, KEMRI, Prof. Solomon Mpoke (left) and Davis Mkoji of Corporate Affairs (right). The inauguration marks a great milestone towards the merging of the Scientific and Ethics review process and alsostrengthen the review process at KEMRI. This will improve the quality of the overall proposals review process while shorting the period of review from the previous 5.6 months to 8 weeks.

Read More . . .

Director, KEMRI, Prof. Solomon Mpoke receives a souvenir gift to from Dr. Thomas Hesse, the Deputy Secretary General of Alexander von Humboldt Stiftung Foundation, his delegation paid a courtesy call. Present in the picture are Ms. Linah Boit, Deputy Director (Administration and Finance).

What's New


Dr. Nancy Quan, Global Vice President for Coco-Cola Research & Development (R&D) signs the Visitors Book when she visited KEMRI Headquarters on Tuesday, March 18th, 2014. Looking on are Dr. Elizabeth Bukusi, Deputy Director in charge of Research and Training and Dr. Charles Mwandawiro, Assistant Director in charge of Partnership & Collaborations.

More . . .

Coming Up



Read More . . .




We have 148 guests online


"To be a leading centre of excellence in human health research."


"To improve human health and quality of life through research, capacity building and service delivery."


"In Search of Better Health"
towards the realization of our Vision


Do you have a complaint?
Click Here